Here, we inducibly re-expressed p16 in vivo in an orthotopic model of pancreatic cancer and examined the impact on these clinically relevant aspects of pancreatic cancer tumour biology. The gene discussed is CDKN2A; the disease is familial pancreatic carcinoma.